568 followers
RCT: Treatment with a once-daily 3.8mg asenapine transdermal system (HP-3070) resulted in a significant improvement in patients with SCZ vs placebo at weeks 4-6 (PANSS positive symptom factor LSMD= − 2.3; P<0.001; d=0.45) https://t.co/pI8D9DSyEo https:/